- SEC Form 4 filed by Executive VP Clark Moore
4 - PEDEVCO CORP (0001141197) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Hardwick Mark K
4 - FIRST MERCHANTS CORP (0000712534) (Issuer)
- SEC Form 6-K filed by Rubico Inc.
6-K - Rubico Inc. (0001943421) (Filer)
- SEC Form 4 filed by Director Harmon Cyrus
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 6-K filed by Rubico Inc.
6-K - Rubico Inc. (0001943421) (Filer)
- Director Tariq Musa sold $255,893 worth of shares (1,951 units at $131.16), decreasing direct ownership by 15% to 11,048 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Butitta Cynthia M
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 11-K filed by Janus Henderson Group plc
11-K - JANUS HENDERSON GROUP PLC (0001274173) (Filer)
- Director Potter Myrtle S sold $204,085 worth of shares (1,556 units at $131.16), decreasing direct ownership by 7% to 20,971 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Garland J. Scott
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 8-K filed by Enanta Pharmaceuticals Inc.
8-K - ENANTA PHARMACEUTICALS INC (0001177648) (Filer)
- Director Mignone Roberto converted options into 528 shares, increasing direct ownership by 6% to 9,482 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Hrustanovic Gorjan
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form FWP filed by Bank of America Corporation
FWP - BANK OF AMERICA CORP /DE/ (0000070858) (Subject)
- SEC Form 4 filed by Director Clark Ian T
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 4 filed by Director Larson Yi
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Amendment: SEC Form 6-K/A filed by VivoPower PLC
6-K/A - VivoPower PLC (0001681348) (Filer)
- SEC Form 11-K filed by Liberty Energy Inc.
11-K - Liberty Energy Inc. (0001694028) (Filer)
- Director Ballal Rahul D. converted options into 2,816 shares, increasing direct ownership by 23% to 15,230 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)